High Dose Rate Brachytherapy in the Treatment of Cervical Cancer: Preliminary Experience with Cobalt 60 Radionuclide Source—A Prospective Study | Zendy

Atara Ntekim | Zendy; A Adenipekun | Zendy; Bidemi I. Akinlade | Zendy; O B Campbell | Zendy

Open Access

High Dose Rate Brachytherapy in the Treatment of Cervical Cancer: Preliminary Experience with Cobalt 60 Radionuclide Source—A Prospective Study

Author(s) -

Atara Ntekim,

A Adenipekun,

Bidemi I. Akinlade,

O B Campbell

Publication year - 2010

Publication title -

clinical medicine insights oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.601

H-Index - 26

ISSN - 1179-5549

DOI - 10.4137/cmo.s5269

Subject(s) - brachytherapy , medicine , cervical cancer , nuclear medicine , external beam radiotherapy , toxicity , rectum , radiation therapy , urology , radiology , cancer , surgery

Iridium-192 is widely used for high-dose rate brachytherapy. Co-60 source with similar geometric and dosimetric properties are now available. It has a longer half life but higher energy than Iridium-192. If Co-60 source can produce similar results, it will be more economical for low resource settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research